New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis

American Journal of Transplantation

Volumn 5, Issue 6, 2005, Pages 1179-1185

  Vincenti, Flavio ^a   Ghiggeri, Gian Marco ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Focal glomerulosclerosis; Permeability factor; Recurrent disease

Indexed keywords

ALPHA ACTININ; ANGIOTENSIN ANTAGONIST; B7 ANTIGEN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY; NEPHRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PODOCIN; STEROID;

FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GENETIC HETEROGENEITY; GENOMICS; HIGH RISK PATIENT; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; PATHOGENESIS; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SHORT SURVEY;

GENETIC PREDISPOSITION TO DISEASE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MEMBRANE PROTEINS; MUTATION; RECURRENCE;

EID: 20544465592     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.00968.x     Document Type: Short Survey

References (53)

1. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF. Recurrence of idiopathic nephritic syndrome after renal transplantation. Lancet 1972; 2: 343-348.
2. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992; 92: 375-383.
3. Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004; 8: 329-333.
4. Senggutuvan P, Cameron JS, Hartley RB et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 1990; 4: 21-28.
5. Ruotsalainen V, Ljungberg P et al. Nephrin is specifically located at the slit-diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A 1999; 96: 7962-7967.
6. Inoue T, Yaoita E, Kurihara H et al. FAT is a component of glomerular slit-diaphragms. Kidney Int 2001; 59: 1003-1012.
7. Reiser J, Kriz W, Kretzler M, Mundel P. The glomerular slit-diaphragm is a modified adherens junction. J Am Soc Nephrol 2000; 11: 1-8.
8. Boute N, Gribouval O, Roselli S et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 2000; 24: 349-354.
9. Roselli S, Gribouval O, Boute N et al. Podocin localizes in the kidney to the slit-diaphragm area. Am J Pathol 2002; 160: 131-139.
10. Schwarz K, Simons M, Reiser J et al. Podocin, a raft-associated component of the glomerular slit-diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001; 108: 1621-1629.
11. Huber TB, Kottgen M, Schilling B, Walz G, Benzing T. Interaction with podocin facilitates nephrin signaling. J Biol Chem 2001; 276: 41543-41546.
12. Kawachi H, Koike H, Kurihara H, Sakai T, Shimizu F. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 2003; 14: 46-56.
13. Luimula P, Sandstrom N, Novikov D, Holthofer H. Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002; 82: 713-718.
14. Doublier S, Ruotsalainen V, Salvidio G et al. Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 2001; 158: 1723-1731.
15. Doublier S, Salvidio G, Lupia E et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-1030.
16. Koop K, Eikmans M, Baelde HJ et al. Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol 2003; 14: 2063-2071.
17. Benigni A, Gagliardini E, Tomasoni S et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 2004; 65: 2193-2200.
18. Schmid H, Henger A, Cohen CD et al. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003; 14: 2958-2966.
19. Putaala H, Soininen R, Kilpelainen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001; 10: 1-8.
20. Roselli S, Heidet L, Sich M et al. Early glomerular filtration defect and severe renal disease in podocin-deficient mice. Mol Cell Biol 2004; 24: 550-560.
21. Shih NY, Li J, Karpitskii V et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312-315.
22. Kim JM, Wu H, Green G et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298-1300.
23. Lenkkeri U, Mannikko M, McCready P et al. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 1999; 64: 51-61.
24. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K. Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 2001; 17: 368-373.
25. Caridi G, Bertelli R, Di Duca M et al. Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 2003; 14: 1278-1286.
26. Caridi G, Bertelli R, Scolari F, Sanna-Cherchi S, Di Duca M, Ghiggeri GM. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 2003; 64: 365.
27. Lagarue G, Branellec A, Blanc C et al. A vascular permeability factor in lymphocyte culture supernatants from patients with nephrotic syndrome. II. Pharmacologic and physiochemical properties. Biomedicine 1975; 23: 73-75.
28. Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 1984; 22: 32-38.
29. Sharma M, Sharma R, Reddy SF, McCarthy ET, Savin VJ. Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 2001; 73: 366-372.
30. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14.
31. Savin VJ, Sharma R, Lovell HB, Welling DJ. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 1992; 3: 1260-1269.
32. Savin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878-883.
33. Musante L, Candiano G, Bruschi M et al. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics 2002; 2: 197-205.
34. Candiano G, Musante L, Carraro M et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 2001; 12: 143-150.
35. Ghiggeri GM, Bruschi M, Candiano G et al. Depletion of clusterin in renal diseases causing nephrotic syndrome. Kidney Int 2002; 62: 2184-2194.
36. Sharma R, Sharma M, McCarthy ET, Ge XL, Savin VJ. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 2000; 58: 1973-1979.
37. Coward RJM, Foster RR, Patton D et al. Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, podocin, and CD2 associated protein in cultured human podocytes. J Am Soc Nephrol 2005; 16: 629-637.
38. Ruf RG, Lichtenberger A, Karle SM et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 2004; 15: 722-732.
39. Weber S, Gribouval O, Esquivel EL et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004; 66: 571-579.
40. Tsukaguchi H, Sudhakar A, Le TC et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 2002; 110: 1659-1666.
41. Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003; 41: 1314-1321.
42. Carraro M, Caridi G, Bruschi M et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002; 13: 1946-1952.
43. Le Berre L, Godfrin Y, Gunther E et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 2002; 109: 491-498.
44. Abbas AK, Sharpe AH. T-cell stimulation: an abundance of B7s. Nat Med 1999; 5: 1345-1346.
45. Reiser J, von Gersdorff G, Loos M et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004; 113: 1390-1397.
46. Ghiggeri GM, Carraro M, Vincenti F. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol Dial Transplant 2004; 19: 1036-1040.
47. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994; 23: 574-581.
48. Kim EM, Striegel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 1994; 45: 1440-1445.
49. Dall'Amico R, Ghiggeri G, Carraro M et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999; 34: 1048-1055.
50. Deegens JKJ, Andresdottir MB, Croockewit S, Wetzels JFM. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation. Transpl Int 2004; 17: 151-157
51. Ingulli E, Tejani A, Butt KM et al. High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation. Transplantation 1990; 49: 219-221.
52. Vincenti F. What's in the pipeline?. New immunosuppressive drugs in transplantation. Am J Transplant 2002; 2: 898-903.
53. Hamburger J. New insight into the pathogenesis of glomerular nephritis offered by the study of renal allografts. Clin Nephrol 1973; 1: 3-5.